Baumruker; Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for Baumruker; Thomas.The latest application filed is for "use of edg receptor binding agents in cancer".
- Baumruker; Thomas - Moedling AT
- Baumruker; Thomas - Wien AU
| Patent | Date |
|---|---|
| Use of EDG Receptor Binding Agents in Cancer App 20140303257 - Baumruker; Thomas ; et al. | 2014-10-09 |
| Use Of Edg Receptor Binding Agents In Cancer App 20090209495 - Baumruker; Thomas ; et al. | 2009-08-20 |
| Biomarker In Inflammatory Diseases App 20080145883 - Baumruker; Thomas ; et al. | 2008-06-19 |
| 2-amino-propanol derivatives Grant 7,326,801 - Albert , et al. February 5, 2 | 2008-02-05 |
| Use of edg receptor binding agents in cancer App 20050215531 - Baumruker, Thomas ; et al. | 2005-09-29 |
| FcyrIII signaling inhibitor assay App 20050181457 - Baumruker, Thomas ; et al. | 2005-08-18 |
| 2-Amino-propanol derivatives App 20040147490 - Albert, Rainer ; et al. | 2004-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 